key: cord-0798244-8m58jpzd
authors: O’Toole, Ronan F.
title: The interface between COVID-19 and bacterial healthcare-associated infections
date: 2021-06-07
journal: Clin Microbiol Infect
DOI: 10.1016/j.cmi.2021.06.001
sha: 52eadf5609af6b92dac45fa42e416fea395c002b
doc_id: 798244
cord_uid: 8m58jpzd

BACKGROUND: A wide range of bacterial infections occur in COVID-19 patients, particularly, in those with severe coronaviral disease. Some of these are community acquired co-infections. OBJECTIVE: To review recent data which indicate the occurrence of hospital-onset bacterial infections, including with antibiotic-resistant isolates, in COVID-19 patients. SOURCES: Using PubMed, the literature was searched using terms including: “COVID-19”; “SARS-CoV-2”; “bacterial infection”; “healthcare-associated infection”; “antibiotic resistance”; “antimicrobial resistance”; “multi-drug resistance”; “Streptococcus”; “Staphylococcus”; “Pseudomonas”; “Escherichia”; “Klebsiella”; “Enterococcus”; “Acinetobacter”; “Haemophilus”; “MRSA”; “VRE”; “ESBL”; “NDM-CRE”; “CR-Ab”; “VRSA”; “MDR”. CONTENT: There is a growing number of reports of bacterial infections acquired by patients with severe COVID-19 after hospital admission. Antibiotic-resistant pathogens found to cause healthcare-associated infections (HAIs) in COVID-19 patients include Methicillin-Resistant Staphylococcus aureus (MRSA), New Delhi Metallo-β-lactamase-producing Carbapenem-Resistant Enterobacterales (NDM-CRE), Carbapenem-Resistant Acinetobacter baumannii (CR-Ab), Extended-Spectrum β-Lactamase (ESBL) Klebsiella pneumoniae, and Vancomycin-Resistant Enterococci (VRE). COVID-19 has impacted bacterial HAIs in a number of ways with an increase in the incidence of NDM-CRE and CR-Ab reported at some hospital sites compared to before the pandemic. Recommended guidelines for antimicrobial stewardship in COVID-19 patient treatment are discussed regarding minimisation of empiric broad-spectrum antibiotic use. Other studies have reported a decrease in MRSA and VRE cases that has been attributed to enhanced infection prevention and control (IPC) practices introduced to minimise intra-hospital spread of COVID-19. IMPLICATIONS: Poorer outcomes have been observed in hospitalised COVID-19 patients with an antibiotic-resistant infection. While heightened IPC measures have been accompanied by a reduction in some HAIs at specific sites, in other situations, COVID-19 has been associated with an increase in bacterial HAI incidence. Further research is needed to define the cost-benefit relationship of maintaining COVID-19-related IPC protocols beyond the pandemic to reduce the burden of HAIs. In addition, the longer-term impact of high usage of certain broad-spectrum antibiotics during the COVID-19 pandemic requires evaluation.

On 31 December 2019, the World Health Organization's (WHO) Western Pacific Regional 57 Office was notified of reports of cases of "pneumonia of unknown cause" from Wuhan, 58 China. (1) The disease, identified as being caused by a novel strain of coronavirus designated 59 severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), was named Coronavirus There is also burnout risk among HCWs associated with a patient-to-nurse ratio above 2:1, 

Timeline: WHO's COVID-19 response

A nosocomial cluster 419 of vancomycin resistant enterococci among COVID-19 patients in an intensive care unit

Multidrug-Resistant Infections and Outcome 423 of Critically Ill Patients with Coronavirus Disease 2019: A Single Center Experience. Microb Drug 424 Resist

Reduction of Multidrug-426 Resistant (MDR) Bacterial Infections during the COVID-19 Pandemic: A Retrospective Study

Hospital-acquired infections in critically-ill XYJ, Venkatachalam I, Ling ML. Unintended consequences of infection prevention and control 470 measures during COVID-19 pandemic

Prevalence of burnout risk and factors associated with 472 burnout risk among ICU nurses during the COVID-19 outbreak in French speaking Belgium. Intensive 473 Crit Care Nurs

Personal protective 475 equipment needs in the USA during the COVID-19 pandemic

Risk of COVID-19 due to Shortage of Personal Protective Equipment

Availability and crisis standards of care for personal 479 protective equipment during fall 2020 of the COVID-19 pandemic: A national study by the APIC 480 COVID-19 task force

Viral and atypical respiratory 482 co-infections in COVID-19: a systematic review and meta-analysis

COVID-19-Associated Invasive Aspergillosis: 486 Data from the UK National Mycology Reference Laboratory

Outbreak of Candida auris infection in a COVID-19 hospital in Mexico. Clin 490 Microbiol Infect

Molecular Epidemiological Investigation of a Nosocomial Cluster of 493 C. auris: Evidence of Recent Emergence in Italy and Ease of Transmission during the COVID-19

Fungal and bacterial coinfections 497 increase mortality of severely ill COVID-19 patients